Adaptive Biotechnologies Corp
NASDAQ:ADPT
Cash Flow Statement
Cash Flow Statement
Adaptive Biotechnologies Corp
Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||||||||||
Net Income |
(46)
|
(52)
|
(56)
|
(61)
|
(69)
|
(82)
|
(100)
|
(122)
|
(146)
|
(155)
|
(171)
|
(190)
|
(207)
|
(230)
|
(232)
|
(222)
|
(200)
|
(195)
|
(191)
|
(196)
|
(225)
|
|
Depreciation & Amortization |
6
|
6
|
7
|
7
|
8
|
8
|
8
|
8
|
9
|
9
|
10
|
12
|
14
|
16
|
19
|
21
|
21
|
21
|
22
|
22
|
22
|
|
Stock-Based Compensation |
11
|
14
|
18
|
21
|
13
|
15
|
18
|
21
|
25
|
29
|
33
|
39
|
43
|
48
|
51
|
53
|
55
|
57
|
60
|
62
|
63
|
|
Other Non-Cash Items |
10
|
9
|
12
|
11
|
11
|
13
|
15
|
21
|
29
|
37
|
46
|
53
|
57
|
61
|
65
|
66
|
67
|
69
|
68
|
68
|
93
|
|
Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
5
|
7
|
9
|
|
Change in Working Capital |
(2)
|
289
|
283
|
270
|
255
|
(44)
|
(43)
|
(44)
|
(41)
|
(67)
|
(68)
|
(53)
|
(57)
|
(46)
|
(60)
|
(73)
|
(72)
|
(74)
|
(54)
|
(54)
|
(46)
|
|
Cash from Operating Activities |
(32)
N/A
|
252
N/A
|
245
-3%
|
227
-8%
|
205
-9%
|
(105)
N/A
|
(120)
-14%
|
(137)
-14%
|
(150)
-10%
|
(176)
-18%
|
(183)
-4%
|
(179)
+2%
|
(193)
-8%
|
(199)
-3%
|
(209)
-5%
|
(208)
+0%
|
(184)
+11%
|
(179)
+3%
|
(155)
+13%
|
(159)
-3%
|
(156)
+2%
|
|
Investing Cash Flow | ||||||||||||||||||||||
Capital Expenditures |
(6)
|
(10)
|
(10)
|
(11)
|
(11)
|
(10)
|
(11)
|
(12)
|
(19)
|
(32)
|
(52)
|
(62)
|
(62)
|
(49)
|
(32)
|
(23)
|
(16)
|
(16)
|
(15)
|
(12)
|
(11)
|
|
Other Items |
7
|
(175)
|
(225)
|
(489)
|
(471)
|
(107)
|
117
|
282
|
(98)
|
(134)
|
(251)
|
(164)
|
243
|
174
|
121
|
191
|
19
|
44
|
75
|
41
|
140
|
|
Cash from Investing Activities |
1
N/A
|
(185)
N/A
|
(235)
-27%
|
(501)
-113%
|
(482)
+4%
|
(117)
+76%
|
106
N/A
|
270
+154%
|
(117)
N/A
|
(166)
-42%
|
(302)
-82%
|
(226)
+25%
|
181
N/A
|
125
-31%
|
88
-29%
|
168
+90%
|
3
-98%
|
28
+872%
|
61
+116%
|
29
-52%
|
130
+349%
|
|
Financing Cash Flow | ||||||||||||||||||||||
Net Issuance of Common Stock |
1
|
1
|
2
|
324
|
325
|
330
|
334
|
289
|
294
|
303
|
303
|
30
|
27
|
15
|
13
|
11
|
8
|
6
|
3
|
3
|
2
|
|
Other |
0
|
0
|
(3)
|
(5)
|
(5)
|
(5)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
125
|
124
|
0
|
0
|
(0)
|
0
|
|
Cash from Financing Activities |
1
N/A
|
1
-33%
|
(1)
N/A
|
318
N/A
|
320
+0%
|
325
+2%
|
333
+2%
|
289
-13%
|
294
+2%
|
303
+3%
|
303
N/A
|
30
-90%
|
27
-10%
|
15
-44%
|
13
-15%
|
136
+950%
|
132
-2%
|
130
-2%
|
128
-2%
|
2
-98%
|
2
+2%
|
|
Change in Cash | ||||||||||||||||||||||
Net Change in Cash |
(30)
N/A
|
68
N/A
|
9
-86%
|
44
+376%
|
44
-2%
|
104
+138%
|
319
+208%
|
422
+32%
|
27
-94%
|
(39)
N/A
|
(181)
-364%
|
(375)
-107%
|
16
N/A
|
(59)
N/A
|
(108)
-83%
|
95
N/A
|
(49)
N/A
|
(20)
+59%
|
33
N/A
|
(128)
N/A
|
(24)
+81%
|
|
Free Cash Flow | ||||||||||||||||||||||
Free Cash Flow |
(39)
N/A
|
243
N/A
|
235
-3%
|
215
-8%
|
194
-10%
|
(115)
N/A
|
(131)
-14%
|
(148)
-14%
|
(169)
-14%
|
(208)
-23%
|
(234)
-13%
|
(241)
-3%
|
(254)
-6%
|
(248)
+3%
|
(241)
+3%
|
(231)
+4%
|
(200)
+13%
|
(195)
+3%
|
(170)
+13%
|
(171)
-1%
|
(167)
+2%
|